Ultrasound-controllable engineered bacteria for cancer immunotherapy

Rapid advances in synthetic biology are driving the development of genetically engineered microbes as therapeutic agents for a multitude of human diseases, including cancer. The immunosuppressive microenvironment of solid tumors, in particular, creates a favorable niche for systemically administered...

Descripción completa

Detalles Bibliográficos
Autores principales: Abedi, Mohamad H., Yao, Michael S., Mittelstein, David R., Bar-Zion, Avinoam, Swift, Margaret B., Lee-Gosselin, Audrey, Barturen-Larrea, Pierina, Buss, Marjorie T., Shapiro, Mikhail G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948203/
https://www.ncbi.nlm.nih.gov/pubmed/35332124
http://dx.doi.org/10.1038/s41467-022-29065-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948203/
https://www.ncbi.nlm.nih.gov/pubmed/35332124
http://dx.doi.org/10.1038/s41467-022-29065-2

Ejemplares similares